Mr. Speaker, I would like to thank the member for Dorval—Lachine—LaSalle for her important question. She is right, we are facing a national public health crisis. We must continue to provide a global, collaborative, and humanitarian response that is evidence-based.
Supervised injection sites are an important harm reduction tool, and they are central to this approach. This week we approved three applications for sites in Montreal. We will continue our efforts to save lives.